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14-3-3Selenoprotein W (SelW) contains a selenocysteine (Sec, U) in a conserved CXXU motif corresponding to the
CXXC redox motif of thioredoxin, suggesting a putative redox function of SelW. We have previously reported
that the binding of 14-3-3 protein to its target proteins, including CDC25B, Rictor and TAZ, is inhibited by the in-
teraction of 14-3-3 protein with SelW. However, the binding mechanism is unclear. In this study, we sought to
determine the binding site of SelW to understand the regulatory mechanism of the interaction between SelW
and 14-3-3 and its biological effects. Phosphorylated Ser(pS) or Thr(pT) residues in RSXpSXP or RXXXp(S/T)XP
motifs are well-known common 14-3-3-binding sites, but Thr41, Ser59, and T69 of SelW, which are computa-
tionally predicted to serve are phosphorylation sites, were neither phosphorylation sites nor sites involved in
the interaction. A mutant SelW in which Sec13 is changed to Ser (U13S) was unable to interact with 14-3-3 pro-
tein and thus did not inhibit the interaction of 14-3-3 to other target proteins. However, other Cys mutants of
SelW(C10S, C33S and C37S) normally interacted with 14-3-3 protein. The interaction of SelW to 14-3-3 protein
was enhanced by diamide orH2O2 and decreased by dithiothreitol (DTT). Taken together, theseﬁndings demon-
strate that the Sec of SelW is involved in its interaction with 14-3-3 protein and that this interaction is increased
under oxidative stress conditions. Thus, SelW may have a regulatory function in redox cell signaling by
interacting with 14-3-3 protein.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Selenoproteins that contain selenium (Se), an essential trace
element for mammals, in the form of selenocysteine (Sec, U) have
been known to regulate signalingprocesses, such as redox signaling, im-
mune responses, antioxidant metabolism and endoplasmic reticulum-
associated degradation [1–5]. In mammals, 25 conserved genes
encoding selenoproteins have been identiﬁed [6,7]. Selenoprotein W
(SelW) is the smallest selenoprotein that contains a conserved Cys-X-
X-Sec (CXXU) motif, which corresponds to the Cys-X-X-Cys (CXXC)
redox motif of the thioredoxin (Trx) active site [8–10]. SelWmay be in-
volved in cellular redox regulation [11]. SelW depletion causes Keshan
disease and white muscle disease in mammals [12,13]. SelW has also
been known to regulate cell cycle progression, cell proliferation and
skeletal muscle differentiation [14–18]. We previously reported that
SelW interacts with 14-3-3 protein, resulting in inhibition of the inter-
action between 14-3-3 protein and its target proteins, which includedithiothreitol; EGFR, epidermal
onance; RICTOR, rapamycin-
ecies; Sec, selenocysteine; TAZ,
University, 1, 5-Ka, Anam-Dong,cell division cycle 25 B (CDC25B), rapamycin-insensitive companion of
mTOR (Rictor) and transcriptional co-activator with PDZ-binding
motif (TAZ) [19–21]. Nevertheless, the binding mechanism is not yet
understood, although the CXXU motif of SelW has been predicted as a
14-3-3-binding site by computational calculations based on known ex-
perimental NMR data [22–24].
14-3-3 protein plays an important role in functionally diverse signal-
ing processes, such as bacterial pathogenesis, neuronal development
and cell growth control, through its interaction with various binding
partners [25–27]. The oligomerization state of 14-3-3 protein, i.e.,
homodimers and heterodimers, is important for its interaction with
many proteins [28]. The function ofmany cellular proteins ismodulated
by interaction with 14-3-3 protein [29]. Protein phosphorylation is re-
quired for interaction with 14-3-3 protein to regulate cell growth, cell
cycle progression and apoptosis [30–34]. The phosphorylated Ser or
Thr of RSXpSXP or RXXXp(S/T)XP motif in target proteins is a well-
known site for binding to 14-3-3 protein [25,35–37]. However, it has
also been reported that 14-3-3 protein interactswith various target pro-
teins, including human telomerase (hTERT), translocated intimin recep-
tor (Tir), amyloid beta-protein precursor intracellular domain fragment
(AICD) and exoenzyme S (ExoS), in a phosphorylation-independent
manner [38–43]. Interestingly, the interaction of AICD with 14-3-3 pro-
tein is prevented by the phosphorylation of AICD at Thr668 [40]. In this
study, we found that phosphorylation is not required for the interaction
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volved in the interaction in a redox-dependentmanner. Thus, SelWmu-
tants in which Ser or Thr of the predicted phosphorylation site is
mutated (T41A, S59A or T69A) were able to interact with 14-3-3 pro-
tein. However, the SelW(U13S) mutant did not interact with 14-3-3
protein and lost the ability to regulate the phosphorylation of Akt at
Ser473 and sensitivity to DNA damage. A previous study suggested
that the Sec of SelWmay be the binding site of 14-3-3 protein, as deter-
mined by computational calculations [24]. Furthermore, we demon-
strated that the binding between SelW and 14-3-3 protein was
enhanced by oxidative stress. These ﬁndings strongly demonstrate
that the Sec of SelW is essential for its redox-modulated interaction
with 14-3-3 protein and that SelW may have regulatory functions in
redox cell signaling by interacting with 14-3-3 protein.
2. Materials and methods
2.1. Cell culture, transfection and reagents
Breast carcinoma MCF7 cells were grown in RPMI 1640 medium
containing 10% fetal bovine serum (FBS) at 37 °C in 5% CO2. Human em-
bryonic kidney 293 (HEK 293) cells were grown in DMEM containing
10% FBS at 37 °C in 5% CO2. The cells were seeded at a density of
5 × 105 cells in 60-mm dishes for transient transfection. Twelve hours
after seeding, the cells were transfected using the Lipofectamine 2000
transfection reagent (Invitrogen, Carlsbad, CA, USA), according to the
manufacturer's instructions. To measure the sensitivity to etoposide,
MCF7 cells were treated with 50 μM etoposide (Sigma, St. Louis, MO,
USA) 24 h after transfection. The cells were then harvested as described
in the ﬁgure legends.
2.2. RNA interference and plasmids
The siSelW used in this study was designed by Invitrogen. The se-
quence for human siSelW was as follows: 5′-CCA CCG GGU UCU UUG
AAG UGA UGG U-3′. Point mutations in SelW(C10S,U13C, U13C, U13S,
C33S, C37S, T41A, S59A, T69A or Δ10–13) were generated by the site-
directed mutagenesis of the cDNA by polymerase chain reaction (PCR)
using the pcDNA 3.1+/SelW plasmid. The HA-14-3-3β plasmids were
kindly provided [32].
2.3. Protein puriﬁcation
The GST and GST-SelW(U13C, U13S, C33S or C37S) proteins were
expressed in E. coli and induced by 1mM IPTG for 16 h at 18°C. The pro-
teins were lysed with lysis buffer containing 50 mM Tris–HCl (pH 8.0),
120 mM NaCl, 0.5% Nonidet P-40 (NP-40), 4 μg/ml aprotinin, 4 μg/ml
leupeptin and 1mMphenylmethylsulfonyl ﬂuoride (PMSF). The cell ly-
sates were then incubated with glutathione beads for 2 h at 4 °C. The
beads were washed with wash buffer containing 20 mM Tris–HCl
(pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.05% SDS and 0.5% NP-40, eluted
with elution buffer containing 50 mM Tris–HCl (pH 8.0), 20 mM KCl,
1 mMDTT and 20 mMGSH for 1 h at 4 °C under rotation andwere sub-
sequently incubated for 10 min at 37 °C. The SelW(C10, C13, C33 or
C37)-His and 14-3-3β-His proteins were expressed in Escherichia coli.
The proteins were induced by 1 mM IPTG for 16 h at 18 °C and lysed
with lysis buffer containing 50 mM NaH2PO4 (pH 8.0), 300 mM NaCl,
10 mM imidazole (pH 7.0), 4 μg/ml aprotinin, 4 μg/ml leupeptin,
1 mM PMSF, 1 mM DTT and 1 mg/ml lysozyme. The cell lysates were
then incubated with Ni-NTA beads for 2 h at 4 °C. The beads were
washed with wash buffer containing 50 mM NaH2PO4 (pH 8.0),
300 mM NaCl, 20 mM imidazole (pH 7.0), eluted with elution buffer
containing 50 mM NaH2PO4 (pH 8.0), 300 mM NaCl, and 250 mM
imidazole (pH 7.0) for 1 h at 4 °C under rotation, and then incubated
for 10 min at 37 °C.2.4. Pull-down assay
Mixtures of the above-described puriﬁed proteins were incubated
with pull-down buffer containing 20 mM HEPES (pH 7.5), 1 mM EDTA
and 1mMPMSF for 1 h at 4 °C under rotation and thenwith glutathione
or NI-NTA beads for 1 min. The beads were washed three times with
wash buffer and then eluted [44].2.5. Antibodies and Western blotting
The cells were washed twice with PBS and lysed with lysis buffer
containing 50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 0.1%
SDS, 1 mM EDTA, 1 mM PMSF, 5 μg/ml aprotinin, 5 μg/ml leupeptin,
3 mM DTT, phosphatase inhibitor, 1 mM NaF, and 1 mM Na3VO4. The
proteins from whole-cell lysates were separated by 6–15% sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the
separated proteins were transferred to a membrane. The membrane
was then blockedwith 5% skimmilk for 1 h and probedwith speciﬁc an-
tibodies. The antibodieswere obtained from the following sources: anti-
Akt, anti-phospho-Akt (Ser473), anti-Rictor and anti-cleaved poly
(ADP-ribose) polymerase (PARP) antibodies were purchased from Cell
Signaling (Danvers, MA, USA); anti-GST and anti-14-3-3 antibodies
were obtained from Santa Cruz Biotech (Santa Cruz, CA, USA); anti-His
and anti-HA antibodies were purchased from ABM (Richmond, BC,
Canada); anti-Flag antibody was purchased from Sigma (St. Louis,
MO, USA); and anti-α-tubulin antibody was obtained from AB Frontier
(Daejeon, Korea). To detect SelW, we used rabbit polyclonal anti-SelW
raised against the HSKKKGDGYVDTESK peptide (synthesized and puri-
ﬁed by Invitrogen) [18].2.6. Immunoprecipitation
The cells were lysed with immunoprecipitation buffer containing
50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% SDS, 5 mM
EDTA, 1 mM PMSF, 5 μg/ml aprotinin, 5 μg/ml leupeptin, 20 mM NaF,
and 2 mMNa3VO4. The lysates were mixed with antibodies overnight,
and the immune complexes were then incubated with Protein A or G
beads for 1.5 h. The beads were washed and boiled with 2× SDS sample
buffer for 3 min. The samples were loaded onto SDS-PAGE gels, trans-
ferred to a membrane, and incubated with primary antibody overnight
at 4 °C. After a further incubation with HRP-conjugated secondary anti-
body for 1 h at room temperature, the immunoreactive bands were
visualized using a West Pico Enhanced ECL Detection kit (Pierce,
Rockford, IL, USA) [45].2.7. Flow cytometry
For cell cycle analysis, MCF7 cells were ﬁxed overnight in ice-cold
70% ethanol. The cells were then collected by centrifugation and
resuspended in PBS. The resuspended cells were treated with RNaseA
(50 μg/ml) for 30 min at RT and then stained with propidium iodide
(50 μg/ml). Subsequently, the cell cycle distribution was analyzed
using a FACSCalibur ﬂow cytometer (BD Bioscience, San Jose, CA, USA).2.8. Phos-tag gel electrophoresis
Theproteins fromwhole-cell lysateswere separated in Phos-tag gels
(Wako). The gel was soaked in a transfer buffer containing 5 mM EDTA
for 30 min at RT and washed with a transfer buffer without EDTA for
10 min at RT. The gel was transferred to a membrane, and the mem-
brane was blocked with 5% skim milk for 1 h and probed with speciﬁc
antibodies [46].
12 Y.H. Jeon et al. / Biochimica et Biophysica Acta 1863 (2016) 10–182.9. Prediction of phosphorylation sites in proteins using NetPhos 2.0 server
The identiﬁcation of the phosphorylation sites of SelW was per-
formed using the online NetPhos 2.0 open access server (http://www.
cbs.dtu.dk/services/NetPhos/). The NetPhos 2.0 server predicts serine,
threonine and tyrosine phosphorylation sites in eukaryotic proteins
based on artiﬁcial neural networks. The threshold value for the predic-
tion is 0.5 [47].
2.10. Protein structure modeling
Discovery Studio programs (version 4.0, Accelrys) were used for
protein structure modeling. The structure of SelW was simulated by
the sequence alignment-based molecular superimposition of mouse
SelW (PDB: 2NPB). The Cys10 and Sec13 residues in SelW sequences
are presented as sticks and balls [48].
3. Results
3.1. The interaction between SelW and 14-3-3 protein does not require
phosphorylation
We previously reported that SelW interacts with 14-3-3 protein to
regulate the activity of target proteins, including CDC25B, Rictor and
TAZ [19–21]. Although we conﬁrmed the interaction between SelW
and 14-3-3 protein, as shown in Fig. 1A, the binding mechanism hasFig. 1. Phosphorylation of SelW is not involved in the interaction with 14-3-3 protein. (A) HEK2
vested 24 h after transfection. The cell extracts were immunoprecipitatedwith anti-HA antibody
ylation potential of possible Ser, Thr and Tyr residues predicted by theNetPhos 2.0 server. Blue, g
and gray horizontal lines show the threshold for the modiﬁcation potential. (C) HEK293 cells w
cellswere harvested 24h after transfection. The cell extractswere immunoprecipitatedwith ant
with CDC25B-Flag or His-SelW(U13C). Twenty-four hours after transfection, the cells were trea
The cell extracts were analyzed by a Phos-tag PAGE gel (top) or conventional SDS-PAGE gel (
experiments.not yet been elucidated. In this study, we expressed a mutant SelW in
which Sec was changed to Cys (U13C). The expression of recombinant
wild-type SelW containing Sec is difﬁcult because the codon for Sec is
UGA. Because 14-3-3 protein strongly interacts with phospho-Ser and
Thr motif of its target proteins [35,36], we investigated whether the
phosphorylation of SelW is required for binding to 14-3-3 protein. The
identiﬁcation of the putative phosphorylation sites of SelW was per-
formed through in silico analyses using the Netphos2.0 computational
tool (Fig. 1B). The results from the analysis indicate that Tyr-19 and -
66, Thr-41 and -69, and Ser-59 residues may be potential phosphoryla-
tion sites in SelW sequences. The Thr or Ser residue among these sites
was mutated to Ala because phosphorylated Ser or Thr has been
known to serve as a binding site in many proteins. In addition, we
found that the resulting mutants (T41A, S59A or T69A) of SelW are
able to interact with 14-3-3 protein (Fig. 1C). We then determined
whether SelW is phosphorylated. As a positive phosphorylation control,
we used CDC25B. It has been demonstrated that CDC25B is phosphory-
lated at Ser151, Ser230 and Ser323 by CHK during the induction of DNA
damage, resulting in its cytoplasmic retention and inactivation by en-
hancing its interaction with 14-3-3 protein [49]. To address this ques-
tion, protein extracts expressing the CDC25B-Flag or His-SelW(U13C)
under DNA damage conditions induced by treatment with etoposide
were separated by electrophoresis using Phos-tag gels (Wako) as de-
scribed in Materials and methods [46]. The phosphorylated CDC25B
was increased within 5 h of treatment with etoposide and then de-
creased with time. We previously reported that cell cycle recovery93 cells were co-transfectedwith His-SelW(U13C) or HA-14-3-3β, and the cells were har-
and then immunoblottedwith anti-His antibody. (B) Graphical presentation of phosphor-
reen and red vertical lines show the phosphorylation potential of Ser, Thr and Tyr residues,
ere co-transfected with His-SelW(U13C, S59A, T41A, or T69A) and HA-14-3-3β, and the
i-HA antibody and immunoblottedwith anti-His antibody. (D)MCF7 cellswere transfected
tedwith 50 μMetoposide. After treatment, the cells were harvested at the indicated times.
bottom) using the indicated antibodies. The data were obtained from three independent
13Y.H. Jeon et al. / Biochimica et Biophysica Acta 1863 (2016) 10–18from G2 arrest caused by DNA damage was observed after 5 h [21].
However, phosphorylated SelW was not detected in Phos-tag gels
(Fig. 1D). These results indicate that SelW interacts with 14-3-3 protein
in a phosphorylation-independent manner.
3.2. The Sec in the CXXUmotif of SelW is essentially required for interaction
with 14-3-3 protein
Because phosphorylation is not required for the interaction between
SelW and 14-3-3 protein, as described above, we then examined the
CXXUmotif of SelW. This motif has been predicted as the site of binding
to 14-3-3 protein by computational analysis based on a NMR study [11,
24]. Fig. 2A is the three-dimensional structure of SelW simulated by the
Discovery Studio program (version 4.0, Accelrys): the Cys10 (*) and
Sec13 (**) residues in theCXXUmotif of SelWare located in the external
loop region [22]. In this study, a CXXU motif-deletion mutant of SelW
was constructed and designated SelW(Δ10-13). To test the interaction
of the SelW(Δ10-13) mutant with 14-3-3 protein, HEK293 cells were
co-transfected with HA-14-3-3β and His-SelW(U13C or Δ10-13). Im-
munoprecipitation experiments showed that the deletion mutant was
unable to bind to 14-3-3 protein (Fig. 2B). We previously reported
that SelW activates the mammalian target of rapamycin complex 2
(mTORC2)/Akt pathway for Akt phosphorylation at Ser473 by
interrupting the binding of Rictor to 14-3-3 protein [19].We thus inves-
tigated whether SelW(Δ10-13) interrupted the interaction between
Rictor and 14-3-3 protein.We found that the interaction between Rictor
and 14-3-3 protein is inhibited by SelW(U13C), but SelW(Δ10-13) did
not interrupt the binding between these proteins (Fig. 2C). We con-
structed further mutants in which Cys or Sec in the CXXU motif wasFig. 2. The CXXUmotif of SelW is involved in the interaction with 14-3-3 protein. (A) Three-dim
(Accelrys). The Cys10 (*) and Sec13 (**) residues in SelW sequences are presented as sticks an
His-SelW(U13C or Δ10-13) and HA-14-3-3β, and the cells were harvested 24 h after transfe
immunoblotted with anti-His antibody. (C) The cell extracts in (B) were immunoprecipitat
E) HEK293 cells were co-transfected with His-SelW(CGAC, CGAS, SGAC or SGAS) and HA-
immunoprecipitatedwith anti-HAor anti-His antibodies andwere then immunoblottedwith anchanged to Ser to ﬁnd speciﬁc interaction site. The point mutants
were designated SelW(CGAS, SGAC or SGAS). HEK293 cells were co-
transfected with HA-14-3-3β and His-SelW(CGAC, CGAS, SGAC or
SGAS), and the interaction of the proteins was then investigated by im-
munoprecipitation. We found that the interaction did not occur by mu-
tation of the Sec at the 13th position to Ser. Thus, neither SelW(SGAS)
nor SelW(CGAS) interacted with 14-3-3 protein. However, the interac-
tion was not affected by the mutation at Cys10 (Figs. 2D and E). To
further validate that the Sec was essentially required for interaction
with 14-3-3 protein, we performed a GST-pull-down assay. GST-
SelW(U13C or U13S) proteins were expressed in E. coli and puriﬁed.
The puriﬁed proteins were conﬁrmed by Coomassie blue staining and
Western blotting and were used as bait in the GST-pull-down assay
against lysates of HEK293 cells overexpressing HA-14-3-3β (Fig. 3A).
As shown in Fig. 3B, SelW(U13C) interacts with HA-14-3-3β, whereas
SelW(U13S) did not. Next, to determinewhether SelWdirectly interacts
with 14-3-3 protein, we performed a GST-pull down assay against puri-
ﬁed 14-3-3β-His. 14-3-3β-His was expressed in E. coli and puriﬁed
(Fig. 3C). As shown in Fig. 3D, SelW(U13C) directly interacts with 14-
3-3β protein in vitro. However, SelW(U13S) was unable to interact
with 14-3-3β protein. To investigate whether other cysteine residues
in SelW are involved in the interaction with 14-3-3 protein, Cys33 and
Cys37 of SelW were mutated to Ser. The resulting GST fusion mutants
were designated GST-SelW(C33S and C37S), respectively, and bothmu-
tants were able to interact with 14-3-3 protein (Fig. 3E). To ensure the
importance of the Sec of SelW for interaction with 14-3-3 protein, we
further constructed four different SelWmutants containing a single cys-
teine residue, designated SelW(C10, C13, C33, and C37), as shown in
Fig. 3F and G. Among the mutants, only SelW containing a cysteineensional structure of SelW (PDB code 2NPB) simulated by Discovery Studio 4.0 programs
d balls, as described in Materials and methods. (B) HEK293 cells were co-transfected with
ction. The cell extracts were immunoprecipitated with anti-HA antibody and were then
ed with anti-HA antibody and were then immunoblotted with Rictor antibody. (D and
14-3-3β, and the cells were harvested 24 h after transfection. The cell extracts were
ti-His or anti-HA antibodies. The datawere obtained from three independent experiments.
Fig. 3. The Sec of SelW interacts with 14-3-3 protein. (A) GST or GST-SelW(U13C and U13S) proteins were puriﬁed and determined by Coomassie blue staining (left) and immunoblotting
with GST antibody (middle) or SelW antibody (right). (B) Each puriﬁed GST or GST-SelW(U13C or U13S) protein was incubatedwith HEK 293 cell lysates overexpressing HA-14-3-3β for
1 h. Themixtureswere incubatedwith glutathione beads for 1min and then immunoblottedwith anti-GST or anti-HA antibodies. (C) 14-3-3β-His proteinwas puriﬁed and determined by
immunoblottingwith anti-His (left) or anti-14-3-3 (right). (D) Each puriﬁed GST-SelW(U13C or U13S) proteinwas incubatedwith puriﬁed 14-3-3β-His for 1 h. The mixtures were incu-
bated with glutathione beads for 1 min and then immunoblotted with anti-SelW or anti-His antibodies. (E) Each puriﬁed GST-SelW(U13C, U13S, U33S or U37S) protein was incubated
with puriﬁed 14-3-3β-His for 1 h. The mixtures were incubated with glutathione beads for 1 min and then immunoblotted with anti-SelW or anti-His antibodies. (F) Mutant sequences
of SelW. The underlines and numbers indicate themutant sites. (G) SelW(C10, C13, C33 or C37)-His proteinswere puriﬁed and determined by Coomassie staining (left) and immunoblot-
tingwith SelW (right) antibody. (H) Each puriﬁed SelW(U13C, U13S, C33S or C37S)-His proteinwas incubatedwith HEK 293 cell lysates overexpressingHA-14-3-3β for 1 h. Themixtures
were incubated with Ni-NTA beads for 1 min and then immunoblotted with anti-His or anti-HA antibodies. The data were obtained from three independent experiments.
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protein. These results indicate that the Sec of SelW is required for inter-
action with 14-3-3 protein.
3.3. Interaction of SelWwith 14-3-3 protein is enhanced by oxidative stress
Musiani et al. proposed a plausible Sec-Se-S-Cys bond in the interac-
tion of SelWwith 14-3-3 protein by a computational approach based on
known experimental NMRdata [24]. In this study,we demonstrated that
the bondwas practically formed in the complex of SelW and 14-3-3 pro-
tein using SelW(U13C), which was able to interact with 14-3-3, as
shown in Fig. 1A. To test the disulﬁde bond between the proteins, weperformed a GST-pull-down assay against puriﬁed 14-3-3β-His with or
without DTT. The interaction between SelW and 14-3-3 protein was sig-
niﬁcantly reduced by treatment with DTT during and after interaction
in vitro (Fig. 4A). We also found that the binding of SelW to 14-3-3
protein was enhanced by diamide, which sustained the oxidized state
of puriﬁed SelW and 14-3-3 protein as a thiol-oxidizing reagent. The in-
creased interaction obtained with diamide was markedly reduced by
DTT (Fig. 4B and C). Furthermore, the binding of SelW to 14-3-3 protein
was dose-dependently increased by H2O2 (Fig. 5A). The increased bind-
ing obtained with H2O2 was not also observed with DTT treatment
(Fig. 5B). These results indicate that the binding of SelW to 14-3-3 pro-
tein is redox-modulated and increased under oxidative stress conditions.
Fig. 4. The binding of SelW to 14-3-3 protein is regulated by diamide and DTT. (A) GST or
GST-SelW(U13C) protein was incubated with 14-3-3β-His protein and 5 mM DTT for 1 h
(left). GST or GST-SelW(U13C) protein was incubated with 14-3-3β-His protein for 1 h.
After incubation, 5mMDTTwas added, and the proteinswere then incubated for an addi-
tional 30 min (right). The mixtures were incubated with glutathione beads for 1 min and
then immunoblotted with anti-SelW or anti-His antibodies. (B) The mixture of GST-
SelW(U13C) and 14-3-3β-His was incubated with 1 mM diamide for 30 min and then
treated with 10 mM DTT for 20 min. The proteins were separated by non-reducing SDS-
PAGE. The separated proteins were immunoblotted with anti-14-3-3 antibody. A stellate
mark (*) indicates the puriﬁed 14-3-3β-His. (C) The mixtures in (B) were incubated
with glutathione beads for 1 min and then immunoblottedwith anti-SelW or anti-His an-
tibodies. The data were obtained from three independent experiments.
Fig. 5.The binding of SelWto 14-3-3 protein is increasedbyH2O2. (A) Themixture of GST-
SelW(U13C) and 14-3-3β-Hiswas incubatedwith 0, 100, 200 or 400 μMH2O2 for 30min.
Themixtureswere incubatedwith glutathionebeads for 1min. The proteinswere separat-
ed by SDS-PAGE. The separated proteins were immunoblotted with anti-His or anti-SelW
antibodies. (B) The mixture in (A) was incubated with 400 μMH2O2 for 30min and then
treated with 10 mM DTT for 20 min. The proteins were separated by SDS-PAGE, and the
separated proteins were immunoblotted with anti-His or anti-SelW antibodies. The data
were obtained from three independent experiments.
15Y.H. Jeon et al. / Biochimica et Biophysica Acta 1863 (2016) 10–183.4. The mutant of SelW (U13S) does not rescue the effect of SelW depletion
We previously reported that the phosphorylation of Akt at Ser473 is
elevated by increasing the binding between SelW and 14-3-3 protein
[19]. We further examinedwhether the Sec at the 13th position was es-
sentially required for Akt phosphorylation through interaction with 14-
3-3 protein. To this end, His-SelW(C10S,U13C, U13C or U13S) was ec-
topically expressed in SelW-knockdown MCF7 breast cancer cells. The
ectopic expression of SelW(C10S,U13C or U13C) mutants, which are
able to interact with 14-3-3 protein, restored the phosphorylation of
Akt at Ser473, and this phosphorylation was decreased by endogenous
SelW knockdown. However, the phosphorylation of Akt at Ser473 was
not recovered in the cells expressing SelW(U13S), which did notinteract with 14-3-3 protein (Fig. 6A). We have previously reported
that the SelW-deﬁcient cells were more sensitive to the anti-cancer
drug etoposide. We then determined the sensitivity of the SelW-
knockdown MCF cells expressing the mutant SelWs by treatment with
etoposide, as schematically illustrated in Fig. 6B. PARP was rapidly
cleaved in SelW-knockdown cells compared with the control cells, and
the cleaved PARP form was restored by SelW(U13C) expression but
not in cells expressing SelW(U13S). A rescue experiment was also per-
formed using FACS analysis. The treatment of the SelW-knockdown
MCF7 cells with etoposide resulted in a markedly larger subG1 popula-
tion compared with that obtained in the control cells. The increase in
the subG1 population in the SelW-knockdown cells was restored by
SelW(U13C) expression but not by SelW(U13S) expression (Fig. 6C).
These results indicate that SelW(U13S) is not able to rescue the effect
of SelW depletion and that Sec-13 is essential for the activity.
4. Discussion
SelW is involved in cell cycle progression, cell growth and muscle
differentiation by interrupting the binding of 14-3-3 protein to its target
proteins [19–21]. Cell growth, proliferation and differentiation are regu-
lated by epidermal growth factor (EGF) [50,51]. It was recently reported
that SelW controls the EGF receptor (EGFR) for regulation of intracellu-
lar signaling pathways, such as the cell cycle. This phenomenon may be
due to the interaction between SelW and 14-3-3 protein [52]. 14-3-3
protein recognizes the phosphorylation motif of target proteins,
Fig. 6.The SelW(U13S)mutant is unable to rescue the effect of SelWknockdown. (A)MCF7 cellswere transiently co-transfectedwith siSelWandHis-SelW(C10S,U13C,U13C orU13S). The
cells were harvested 24 h after transfection and were analyzed by Western blot using the indicated antibodies. α-Tubulin served as a loading control. (B) The experimental plan is de-
scribed (top). MCF7 cells were transiently transfected with siSelW and His-SelW(U13C or U13S). Twenty-four hours after transfection, the cells were treated with 50 μM etoposide.
The cellswere harvested at the indicated times andwere then analyzed byWestern blot using the indicated antibodies.α-Tubulin served as a loading control (left). The quantity of cleaved
PARP expression represents the average values at the indicated times. The graph indicates the results from three independent experiments. Error bars represent±standarddeviation (s.d.)
(right). (C) TheMCF7 cells in (B) were harvested at the indicated times. The subG1 population of the cells was determined by FACS analysis at the indicated times, and data were obtained
using the CellQuest Pro program (BD Biosciences) (left). The graph indicates the results from three independent experiments. The error bars in the graph indicate ±standard deviations
(s.d.) (right). The data were obtained from three independent experiments.
16 Y.H. Jeon et al. / Biochimica et Biophysica Acta 1863 (2016) 10–18including CDC25B [31,49], TAZ [32,53,54] and Rictor [55,56]. The phos-
phorylation of TAZ at Ser89 and the phosphorylation of Rictor at
Thr1135 generate a 14-3-3-binding site. Replacing Ser89 with Ala
(S89A) in TAZ and Thr1135 with Ala (T1135A) in Rictor completely
abolishes the interaction of these proteins with 14-3-3 protein. Addi-
tionally, the binding of TAZ to 14-3-3 protein is inhibited by increasing
amounts of K231a (a Ser/Thr inhibitor) [32,35,37,56–58]. The phos-
phorylation of TAZ at Ser89 is increased with okadaic acid (OA), which
is an inhibitor of protein phosphatase 1 and 2A. The binding of TAZ to
14-3-3 protein is increased by OA [59]. We previously reported that
SelW decreases the binding of TAZ to 14-3-3 protein, which is increased
by treatment with OA [20].
In this study, we investigated the binding site of SelW to 14-3-3 pro-
tein. To this end, the phosphorylation sites in SelW sequenceswere pre-
dicted through in silico analysis. Because the phosphorylation of a Ser or
Thr of the binding partners of 14-3-3 protein is usually required, we
changed the predicted Ser/Thr but not the Tyr phosphorylation sites of
SelW. The mutants in which Ser59, Thr41 or Thr69 was replaced withAla (S59A, T41A or T69A) in SelWwere able to interactwith 14-3-3 pro-
tein (Fig. 1C). We also found that SelW was a non-phosphorylated pro-
tein by analyzing the mobility of SelW using Phos-tag gels (Fig. 1D).
These ﬁndings indicate that SelW may interact with 14-3-3 protein in
a phosphorylation-independent manner. We found that the Sec of
SelW is exclusively required for the interaction with 14-3-3 protein
and that the interaction did not occur in the presence of DTT (Figs. 2,
3, and 4A). Although we did not ﬁnd the speciﬁc amino acid residue of
14-3-3 protein that interacts with SelW, cysteine may be a possible
binding site. A previous study predicted that Cys191 and Cys195 in
14-3-3β and γ, respectively, are the sites responsible for binding to
SelW [24].
We previously reported that SelW regulates the interaction of 14-3-
3 protein with CDC25B during recovery from G2 arrest induced by γ-
irradiation (IR) or etoposide treatment [21]. The DNA damage induced
by IR or etoposide generates reactive oxygen species (ROS) in cells
[60]. The interaction of SelW with 14-3-3 protein is increased by the
ROS generated during DNA damage [21]. In addition, the binding
17Y.H. Jeon et al. / Biochimica et Biophysica Acta 1863 (2016) 10–18between SelW and 14-3-3 protein was found to be dose-dependently
increased by H2O2 (Fig. 5). ROS, which are essential for initiating
redox reactions, are required for cell proliferation, adhesion, migration,
metastasis [61,62] and cancer growth [63]. It was recently reported that
phosphatase slingshots-1L (SSH-1L) interacts with 14-3-3 protein,
which results in decreasing the activity of SSH-1L to regulate the sub-
strate, coﬁlin [64,65]. SSH-1L binding to 14-3-3 protein is diminished
by increasing levels of ROS. The SSH-1L-coﬁlin pathways is activated
by ROS through oxidation of 14-3-3 protein [66,67]. The interaction of
SelW with 14-3-3 protein was also increased by an oxidant, diamide,
as shown in Fig. 4B and C.
When the binding between SelW and 14-3-3 protein was increased,
Akt phosphorylation at Ser473 was elevated [19]. In this study, we
found that Sec is required for the phosphorylation by the ectopic ex-
pression of various mutant SelWs in endogenous SelW-knockdown
MCF7 cells, as shown in Fig. 6A. Furthermore, we found that etoposide
sensitivity was increased in the cells expressing the SelW mutant in
which Sec was changed to Ser (Fig. 6B and C).
Taken together, our ﬁndings suggest that the Sec of SelW is essential
for redox-regulated interaction with 14-3-3 protein and that SelWmay
have regulatory functions in redox cell signaling by interactingwith 14-
3-3 protein.
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